Ezetimibe and Kaletra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Kaletra (lopinavir; ritonavir). Common drug interactions include anhedonia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Kaletra. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Kaletra?

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. eHealthMe is studying from 23,070 Kaletra users. Check the latest studies of Kaletra.

On Jul, 20, 2026

13 people who take Ezetimibe and Kaletra together, and have interactions are studied.

Ezetimibe and Kaletra drug interactions.

What are the common drug interactions of Ezetimibe and Kaletra, by gender? *:

female:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Chronic kidney disease
Emotional distress
Pain
Anaemia (lack of blood)
Arthralgia (joint pain)
Depression
Dizziness

male:

Emotional distress
Pain
Haematuria (presence of blood in urine)
Hip arthroplasty
Malaise (a feeling of general discomfort or uneasiness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nausea (feeling of having an urge to vomit)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis (death of bone)
Osteopenia (a condition where bone mineral density is lower than normal)

What are the common drug interactions of Ezetimibe and Kaletra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bone density decreased
Bone loss
Chronic kidney disease
Emotional distress
Femoral neck fracture (neck of femur bone fracture)
Haematuria (presence of blood in urine)
Hip arthroplasty
Nausea (feeling of having an urge to vomit)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis (death of bone)

50-59:

Drug hypersensitivity
Emotional distress
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Malaise (a feeling of general discomfort or uneasiness)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis postmenopausal (weak bone with possibility to break after stopped menstrual cycles)
Pain
Paranasal cyst (cyst near the nose)

60+:

Abnormal behaviour
Confusional state
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

What are the existing conditions these people have? *

Hiv Infection: 8 people, 61.54%
Pain: 2 people, 15.38%
Lipoatrophy (localized loss of fat tissue): 2 people, 15.38%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 15.38%
Colitis (inflammation of colon): 2 people, 15.38%
Cardiac Failure: 2 people, 15.38%
High Blood Pressure: 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Kaletra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously